BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

FDA Approves Roche (RHHBY)'s Tamiflu for Infants


12/27/2012 6:35:16 AM

The FDA recently expanded the approved use of oseltamivir phosphate to treat children older than 2 weeks who have exhibited symptoms of flu for no longer than 2 days. Oseltamivir (Tamiflu, Roche) has not been approved for prevention of flu infection in this population, however, and the safety and efficacy to treat flu infection has not been established in children younger than 2 weeks old. Oseltamivir was approved in 1999 to treat adults infected with flu who demonstrated symptoms for no longer than 2 days. It has since been approved to treat flu in children aged 1 year and older who have exhibited symptoms of flu for no longer than 2 days, and to prevent flu in adults and children aged 1 year and older. Although there is a fixed dosing regimen for patients aged 1 year and older according to weight categories, the dosing for younger children must be calculated individually based on their exact weight. Children should receive 3 mg per kg twice daily for 5 days, a dosage that will require a different dispenser than that currently co-packaged with oseltamivir.

Read at News Release
Read at Nurse.com
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->